Indivisible Partners’s VanEck Biotech ETF BBH Stock Holding History

Indivisible Partners’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$657K	Buy	+2,685	New	+$600K	0.03%	377

Other funds holding BBH

Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return

L.J. Altfest & Co New York $1.01B AUM 24.77% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return

Blue Fin Capital Warren, Rhode Island $742M AUM 23.99% 1-Year Est. Return

HFAS

Hummer Financial Advisory Services Chicago, Illinois $153M AUM 19.62% 1-Year Est. Return

Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return

Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Plan A Wealth Lincoln, Nebraska $280M AUM 16.85% 1-Year Est. Return

Indivisible Partners's BBH Position: Q3 2026 in Review

Indivisible Partners opened a new position in VanEck Biotech ETF (BBH) in Q3 2026: 2,685 shares worth $657K. The stake represents 0.03% of the portfolio and ranks #377 among its holdings.

25 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

Indivisible Partners held 2,685 shares of VanEck Biotech ETF worth $657K as of Q3 2026.
VanEck Biotech ETF was a new Indivisible Partners position in Q3 2026.
VanEck Biotech ETF made up 0.03% of Indivisible Partners's portfolio in Q3 2026, its #377 holding.
25 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.